Cargando…

Role of STAT3 pathway in genitourinary tumors

The STAT3 is often dysregulated in genitourinary tumors. In prostate cancer, STAT3 activation correlates with Gleason score and pathological stage and modulates cancer stem cells and epithelial–mesenchymal transition. In addition, STAT3 promotes the progression from carcinoma in situ to invasive bla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santoni, Matteo, Conti, Alessandro, Piva, Francesco, Massari, Francesco, Ciccarese, Chiara, Burattini, Luciano, Cheng, Liang, Lopez-Beltran, Antonio, Scarpelli, Marina, Santini, Daniele, Tortora, Giampaolo, Cascinu, Stefano, Montironi, Rodolfo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137995/ https://www.ncbi.nlm.nih.gov/pubmed/28031890 http://dx.doi.org/10.4155/fso.15.13

Ejemplares similares

Microbiome and Cancers, With Focus on Genitourinary Tumors
por: Cimadamore, Alessia, et al.
Publicado: (2019)

Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma
por: Piva, Francesco, et al.
Publicado: (2015)

Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer
por: Cimadamore, Alessia, et al.
Publicado: (2020)

Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers
por: Santoni, Matteo, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?
por: Modena, Alessandra, et al.
Publicado: (2016)

Editorial: Emerging Biomarkers in Genitourinary Tumors
por: Montironi, Rodolfo, et al.
Publicado: (2019)

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors
por: Santoni, Matteo, et al.
Publicado: (2014)

Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
por: Cimadamore, Alessia, et al.
Publicado: (2019)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
por: Montironi, Rodolfo, et al.
Publicado: (2020)

Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
por: Montironi, Rodolfo, et al.
Publicado: (2021)

Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Acquired hemophagocytic syndrome: comment to the case report
por: Ciccarese, Chiara, et al.
Publicado: (2015)

Immunotherapy in renal cell carcinoma: latest evidence and clinical implications
por: Santoni, Matteo, et al.
Publicado: (2018)

Exploring Small Extracellular Vesicles for Precision Medicine in Prostate Cancer
por: Giulietti, Matteo, et al.
Publicado: (2018)

New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?
por: Aurilio, Gaetano, et al.
Publicado: (2020)

Towards a new WHO classification of renal cell tumor: what the clinician needs to know—a narrative review
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Narrative review: update on immunotherapy and pathological features in patients with bladder cancer
por: Aurilio, Gaetano, et al.
Publicado: (2021)

Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
por: Di Nunno, Vincenzo, et al.
Publicado: (2018)

New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
por: Cimadamore, Alessia, et al.
Publicado: (2018)

Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer
por: Mollica, Veronica, et al.
Publicado: (2019)

The Identification of Immunological Biomarkers in Kidney Cancers
por: Lopez-Beltran, Antonio, et al.
Publicado: (2018)

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
por: Aurilio, Gaetano, et al.
Publicado: (2020)

Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges
por: Santoni, Matteo, et al.
Publicado: (2019)

Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?
por: Mollica, Veronica, et al.
Publicado: (2021)

Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Is There a Role for Immunotherapy in Prostate Cancer?
por: Rizzo, Alessandro, et al.
Publicado: (2020)

TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?—a narrative review
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder
por: Santoni, Matteo, et al.
Publicado: (2012)

Treating Prostate Cancer by Antibody–Drug Conjugates
por: Rosellini, Matteo, et al.
Publicado: (2021)

Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor
por: Mollica, Veronica, et al.
Publicado: (2019)

Does prostate acinar adenocarcinoma with Gleason Score 3 + 3 = 6 have the potential to metastasize?
por: Montironi, Rodolfo, et al.
Publicado: (2014)

Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer Environments
por: Santoni, Matteo, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
por: Lopez-Beltran, Antonio, et al.
Publicado: (2021)

The Human Microbiota and Prostate Cancer: Friend or Foe?
por: Massari, Francesco, et al.
Publicado: (2019)

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
por: Conti, Alessandro, et al.
Publicado: (2013)

Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians
por: Gasparrini, Silvia, et al.
Publicado: (2019)

Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
por: Mollica, Veronica, et al.
Publicado: (2021)

Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States
por: Santoni, Matteo, et al.
Publicado: (2021)

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma
por: Santini, Daniele, et al.
Publicado: (2016)

Long Non-coding RNAs in Prostate Cancer with Emphasis on Second Chromosome Locus Associated with Prostate-1 Expression
por: Cimadamore, Alessia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n7qbs7frhdo15i3j1bqj9cmrfv